- Home
- HNNA vs BYSI Comparison
HNNA vs BYSI Comparison
Compare HNNA & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HNNA
- BYSI
- Stock Information
- Founded
- HNNA 1989
- BYSI 2010
- Country
- HNNA United States
- BYSI United States
- Employees
- HNNA N/A
- BYSI N/A
- Industry
- HNNA Investment Managers
- BYSI Biotechnology: Pharmaceutical Preparations
- Sector
- HNNA Finance
- BYSI Health Care
- Exchange
- HNNA Nasdaq
- BYSI Nasdaq
- Market Cap
- HNNA 87.6M
- BYSI 72.1M
- IPO Year
- HNNA N/A
- BYSI 2017
- Fundamental
- Price
- HNNA $10.75
- BYSI $1.67
- Analyst Decision
- HNNA
- BYSI
- Analyst Count
- HNNA 0
- BYSI 0
- Target Price
- HNNA N/A
- BYSI N/A
- AVG Volume (30 Days)
- HNNA 10.6K
- BYSI 10.4K
- Earning Date
- HNNA 02-13-2025
- BYSI 01-01-0001
- Dividend Yield
- HNNA 5.12%
- BYSI N/A
- EPS Growth
- HNNA 75.66
- BYSI N/A
- EPS
- HNNA 1.12
- BYSI N/A
- Revenue
- HNNA $33,210,000.00
- BYSI $1,876,000.00
- Revenue This Year
- HNNA N/A
- BYSI N/A
- Revenue Next Year
- HNNA N/A
- BYSI N/A
- P/E Ratio
- HNNA $9.59
- BYSI N/A
- Revenue Growth
- HNNA 38.27
- BYSI 21.03
- 52 Week Low
- HNNA $6.60
- BYSI $1.43
- 52 Week High
- HNNA $13.88
- BYSI $3.75
- Technical
- Relative Strength Index (RSI)
- HNNA 34.03
- BYSI 45.39
- Support Level
- HNNA $10.66
- BYSI $1.61
- Resistance Level
- HNNA $10.99
- BYSI $1.74
- Average True Range (ATR)
- HNNA 0.37
- BYSI 0.10
- MACD
- HNNA -0.10
- BYSI -0.01
- Stochastic Oscillator
- HNNA 4.76
- BYSI 22.22
About HNNA Hennessy Advisors Inc.
Hennessy Advisors Inc is an investment management company, engaged in the managing and marketing of open-end mutual funds branded as the Hennessy Funds. It offers domestic equity, sectors, and specialty, balanced, and fixed income products. It also provides investment advisory services and shareholder services to the Hennessy Funds which include managing the composition of each fund's portfolio, including the purchase, retention, and disposition of portfolio securities as per the Fund's investment objectives, policies, and restrictions; conducting investment research, and monitoring compliance with each fund's investment restrictions and applicable laws and regulations.
About BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It has two reportable segments Plinabulin pipeline and the TPD platform.